Calix Ltd (ASX: CXL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Calix Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $240.37 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 215.58 million
Earnings per share -0.228
Dividend per share N/A
Year To Date Return 13.78%
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Calix Ltd (ASX: CXL)
    Latest News

    A group of happy corporate bankers clap hands
    Share Gainers

    Calix (ASX:CXL) share price leaps 6% as multi-billion dollar opportunities spruiked at AGM

    Big potential for clean technology puts Calix in the top gainers today...

    Read more »

    green arrow representing a rise in the share price
    Share Gainers

    Why Calix, Imugene, Legacy Iron Ore, and Lovisa shares are charging higher

    These ASX shares are on form today...

    Read more »

    A green-caped superhero reveals their identity with a big dollar sign on their chest.
    Share Gainers

    Here's why the Calix (ASX:CXL) share price is up 17% on Friday

    Calix is flying on its latest technological development...

    Read more »

    A businessman leaps in the air outside a city building in the CBD.
    Share Gainers

    Why Calix, Fortescue, Link, and Zip shares are jumping today

    These ASX shares are ending the week strongly...

    Read more »

    A man takes his dividend and leaps for joy.
    Share Gainers

    Why the Calix (ASX:CXL) share price is shooting 10% higher today

    The Calix Ltd (ASX: CXL) share price is charging notably higher on Thursday morning. At the time of writing, the…

    Read more »

    A graphic image of three upward pointing arrows with smoke coming from their bottoms, indicating the arrows are taking off just like the Althea share price today
    Broker Notes

    Leading broker tips Calix (ASX:CXL) share price to rise 57%

    Here's why this broker is bullish on Calix...

    Read more »

    share price rise
    Share Gainers

    Why Accent, Calix, Pilbara Minerals, & Starpharma shares are racing higher

    These ASX shares are having very positive days...

    Read more »

    a man sits on a rocket propelled office chair and flies high above a city
    Record Highs

    Why the Calix (ASX:CXL) share price is surging 20% to a new all-time high

    Carbon Direct's investment sees it take a 7% stake in subsidiary LEILAC Group.

    Read more »

    Three young nerds dressed in suits with thinking caps and lightbulbs
    Ask a Fund Manager

    Here are the 3 hottest ASX shares to buy right now: expert

    Ask A Fund Manager: Shaw and Partners' Adam Dawes reveals 2 hot buys right now and one stock that he'd…

    Read more »

    man pointing up at a rising red line which represents a growing share price
    Share Market News

    5 ASX shares under $10 that have more than doubled in the past year

    Investors have been left gobsmacked by the returns of these 5 ASX-listed companies...

    Read more »

    Three people sit on safe cheering with pizza on table
    Share Market News

    3 tempting ASX shares that rocketed after their results

    These stocks shot up in August, but one expert reckons it's not too late to get a pizza the action...

    Read more »

    People holding banners protesting against climate change
    Share Market News

    What could the latest climate report mean for ASX 200 shares?

    What does the IPCC climate report mean for ASX 200 shares?

    Read more »

    Frequently Asked Questions

    Calix Ltd does not pay shareholder dividends at this time. 

    Calix listed on the ASX on 20 July 2018.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Sep 2005 $0.0150 100.00% Final 07 Oct 2005

    CXL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Calix Ltd

    Calix Ltd (ASX: CXL) is an Australian technology company. It has developed a patented, platform technology that essentially involves grinding minerals to between one-hundredth and one-thousandth of a millimetre in size, and then "flash" heating them in a reactor. As trapped gases in the minerals are released, they create highly porous honeycomb-like structures with similar properties to nanomaterials, but without the associated safety issues and costs. Calix's technology also allows for the separation of carbon dioxide, making it attractive to industries and companies looking to reduce carbon emissions.

    Calix's technology is being used globally across many industries and sectors. These include advanced battery development, water and wastewater treatment, sustainable food, and biotechnology. The company has operations in Australia, New Zealand, Asia, Europe, and the United States.

    CXL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Feb 2026 $1.12 $-0.02 -1.76% 232,874 $1.15 $1.17 $1.11
    26 Feb 2026 $1.14 $0.05 4.63% 258,715 $1.08 $1.18 $1.06
    25 Feb 2026 $1.08 $0.05 4.85% 761,153 $1.01 $1.13 $1.01
    24 Feb 2026 $1.03 $0.02 1.98% 482,414 $1.01 $1.08 $1.00
    23 Feb 2026 $1.01 $-0.04 -3.81% 845,398 $1.00 $1.14 $1.00
    20 Feb 2026 $1.05 $-0.13 -11.02% 1,561,288 $1.19 $1.19 $1.04
    19 Feb 2026 $1.18 $-0.41 -25.79% 2,177,669 $1.52 $1.54 $1.18
    18 Feb 2026 $1.59 $0.03 1.92% 203,283 $1.55 $1.65 $1.55
    17 Feb 2026 $1.56 $-0.10 -6.02% 339,026 $1.69 $1.69 $1.51
    16 Feb 2026 $1.66 $0.01 0.61% 582,715 $1.72 $1.77 $1.61
    13 Feb 2026 $1.65 $-0.05 -2.94% 394,697 $1.67 $1.69 $1.55
    12 Feb 2026 $1.70 $0.02 1.19% 322,521 $1.68 $1.70 $1.61
    11 Feb 2026 $1.68 $0.01 0.60% 422,397 $1.67 $1.71 $1.61
    10 Feb 2026 $1.67 $0.19 12.84% 1,056,114 $1.48 $1.74 $1.46
    09 Feb 2026 $1.48 $0.15 11.28% 555,061 $1.34 $1.50 $1.31
    06 Feb 2026 $1.33 $-0.14 -9.52% 941,273 $1.42 $1.46 $1.27
    05 Feb 2026 $1.47 $-0.07 -4.55% 749,005 $1.53 $1.53 $1.42
    04 Feb 2026 $1.54 $0.05 3.36% 779,647 $1.52 $1.60 $1.46
    03 Feb 2026 $1.49 $0.17 12.83% 1,089,804 $1.33 $1.53 $1.31
    02 Feb 2026 $1.33 $0.05 3.94% 730,813 $1.20 $1.35 $1.17
    30 Jan 2026 $1.27 $0.05 4.10% 734,644 $1.20 $1.30 $1.17

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Dec 2025 Catriona Deans Issued 179,167 $107,500
    Director remuneration.
    05 Dec 2025 Helen Fisher Issued 112,500 $67,500
    Director remuneration.
    05 Dec 2025 Sarah Ryan Issued 112,500 $67,500
    Director remuneration.
    05 Dec 2025 Peter Dixon Issued 112,500 $67,500
    Director remuneration.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catriona Alison Deans Non-Executive DirectorNon-Executive Chairman Mar 2023
    Ms Deans is also a member of the Investment Committee at Main Sequence Ventures (CSIRO's innovation fund) and a Member of the AICD Corporate Governance Committee. Alison's previous directorships include Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. In her executive career, Alison was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, CEO of netus Pty Ltd (a technology investment company acquired by Fairfax), and a consultant with McKinsey & Company. She is member of Risk Management Committee and the Sustainability Committee.
    Ms Helen E Fisher Non-Executive Director Sep 2020
    Ms Fisher is Managing Director and CEO of Bio Capital Impact Fund (BCIF). Prior to establishing BCIF, Helen was a partner of Deloitte for over 10 years and led Deloitte's Life Sciences industry practice in Australia for five years, having had many years of experience in the Life Sciences and Health Care industry. She also specialized in Financial Services, servicing some of the Australian banks and funds and has been involved in setting up several international funds, as well as advised on several M&A deals. Helen provided strategic advice to publicly listed multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore expansions. She is Chair of the Risk Management Committee and member of the Sustainability Committee.
    Dr Philip (Phil) Hargraves Hodgson Chief Executive OfficerManaging Director Feb 2014
    Dr Hodgson has a technical and commercial background from a career with Shell, where for over 14 years he developed depth of experience across all sectors of the downstream oil industry, including refining and supply, marketing and sales, pricing strategy, risk management, corporate strategy, and mergers and acquisitions. From 2007 to 2013, Phil ran his own consultancy, providing project development, commercial, M&A, and management expertise to several sectors, including LNG, biofuel, clean coal, geothermal energy, building products, logistics and fast-moving consumer goods. He is also member of Technology Committee.
    Dr Sarah Elizabeth Ryan Non-Executive Director Jan 2024
    Dr Ryan brings global engineering and commercial experience, encompassing private equity, investment management, energy sector operations, marketing, research, and team management. With a particular emphasis on innovation and technology enabled solutions. Dr Ryan is also a Strategic Advisory Panel Member of the ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide and Chair of the Energy Forum for the Australian Academy of Technological Sciences and Engineering.
    Mr Peter Matthew Francis Dixon Non-Executive Director Jan 2024
    Mr Dixon has 25 years of experience across the legal, investment banking and funds management sectors, Mr Dixon brings expertise across corporate strategy, investment management, corporate advisory (including equity capital markets) and legal governance issues to the Calix board. Mr Dixon is currently Chief Strategy Officer for HPX. Mr Dixons investment banking and legal experience includes private legal practice experience at Mallesons Stephen Jacques in Sydney and Linklaters in London, as well as over nine years executive experience as an investment banker.
    Mr Darren Charles Chief Financial OfficerCompany Secretary
    -
    Darren Charles Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    J P Morgan Nominees Australia Pty Limited 43,179,876 20.10%
    UBS Nominees Pty Ltd 22,789,549 10.61%
    Citicorp Nominees Pty Limited 13,585,438 6.33%
    HSBC Custody Nominees (Australia) Limited 13,412,595 6.24%
    Nicholas Merriman 8,108,286 3.78%
    Mr Paul Crowther 5,389,438 2.51%
    Dr Mark Geoffrey Sceats 3,655,264 1.70%
    Mark Geoffrey Sceats <Sceats Superannuation Fund> 2,847,344 1.33%
    Pigeons Super Pty Limited <The Hodgson Family S/F A/C> 2,461,597 1.15%
    BNP Paribas Nominees Pty Ltd <HUB24 Custodial Serv Ltd> 2,325,844 1.08%
    Phil Hodgson 1,888,309 0.88%
    J P Morgan Nominees Australia Pty Limited 1 1,799,141 0.84%
    Mr Jacob Shields Ulrich 1,703,133 0.79%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 1,318,636 0.61%
    Jeneil Super Pty Ltd <Jeneil Super Fund A/C> 1,266,388 0.59%
    Mr John Andrew Hamilton 1,223,639 0.57%
    Mr Timothy John Reed & Ms Karola Brent <The Private Fund S/F A/C> 1,169,000 0.54%
    Cy Capital Pty Ltd 1,135,000 0.53%
    BNP Paribas Noms Pty Ltd 1,106,402 0.52%
    Turnbull Super Fund Pty Ltd <The Turnbull Super Fund A/C> 1,057,719 0.48%

    Profile

    since

    Note